Leah Kosyakovsky

247 Articles

The ADVENT of Pulsed Field Ablation for Atrial Fibrillation: just as effective and safe as traditional thermal ablation, but faster

Key Points: ADVENT was the first randomized controlled trial comparing pulsed field…

FIRE: Complete revascularization better than culprit-only strategy for elderly with MI and MVD

Key Points The FIRE trial aimed to address the lack of evidence…

Meta-analysis demonstrates that IV Iron is associated with reduced HF hospitalizations in HF patients with iron deficiency

Key Points: Iron-deficiency is common in heart failure (HF) and associated with…

ECLS-SHOCK: ECMO does not reduce mortality in acute MI-related cardiogenic shock compared to control

Key Points: The use of ECLS has increased substantially over the past…

STEP-HFpEF: Semaglutide reduces heart failure symptoms and body weight in HFpEF patients at one year

Key Points: More than 80% of patients with HFpEF are overweight or…

NOAH-AFNET 6: No benefit of oral anticoagulation among patients with atrial high-rate episodes in the absence of confirmed AF

Key Points This trial randomized elderly patients without a known diagnosis of…

HOST-IDEA: 3-Month DAPT Noninferior to 12-Month DAPT in Patients Undergoing PCI using third-generation stents

Key Points: Among patients undergoing PCI using third-generation DES with ultrathin struts…

UK Biobank Analysis: Self-reported LCHF Diet May be Linked to Cardiac Events

Key Points: In spite of the increase popularity of low-carbohydrate high-fat diet…

hsCRP is a Stronger Predictor of CV Events and Death than LDL-C in High-Risk Patients on Statins

Key Points: Both inflammatory risk and hyperlipidemia and crucial risk factors for…

FREEDOM COVID: Therapeutic dose anticoagulation does not reduce MACE in non-critically ill COVID-19 patients

Key Points: There have been conflicting data on the role and recommended…

STELLAR: Sotatercept improves 6MWD in PAH patients and WHO FC II-III

Key Points: Sotatercept is a novel activin signaling inhibitor which was designed…

Dapagliflozin Reduces PCWP at Rest and Exercise, Plasma Volume, and Weight in HFpEF patients

Key Points: SGLT2i therapy reduces HF hospitalizations and CV mortality in HFpEF,…